ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
06 2021
Historique:
received: 25 02 2021
accepted: 17 03 2021
pubmed: 30 3 2021
medline: 29 6 2021
entrez: 29 3 2021
Statut: ppublish

Résumé

Online magnetic resonance-guided radiotherapy (oMRgRT) represents one of the most innovative applications of current image-guided radiation therapy (IGRT). The revolutionary concept of oMRgRT systems is the ability to acquire MR images for adaptive treatment planning and also online imaging during treatment delivery. The daily adaptive planning strategies allow to improve targeting accuracy while avoiding critical structures. This ESTRO-ACROP recommendation aims to provide an overview of available systems and guidance for best practice in the implementation phase of hybrid MR-linac systems. Unlike the implementation of other radiotherapy techniques, oMRgRT adds the MR environment to the daily practice of radiotherapy, which might be a new experience for many centers. New issues and challenges that need to be thoroughly explored before starting clinical treatments will be highlighted.

Identifiants

pubmed: 33775715
pii: S0167-8140(21)06162-4
doi: 10.1016/j.radonc.2021.03.025
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

146-154

Subventions

Organisme : Department of Health
ID : ICA-SCL-2018-04-ST2-002
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Stefanie Corradini (S)

Department of Radiation Oncology, University Hospital, LMU Munich, Germany. Electronic address: stefanie.corradini@med.uni-muenchen.de.

Filippo Alongi (F)

Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy, University of Brescia, Italy.

Nicolaus Andratschke (N)

Department of Radiation Oncology, University Hospital of Zurich, University of Zurich, Switzerland.

David Azria (D)

Department of Radiation Oncology, University Federation of Radiation Oncology Montpellier-Nîmes, ICM, Montpellier Cancer Institute, University of Montpellier, INSERM U1194, France.

Omar Bohoudi (O)

Department of Radiation Oncology, Amsterdam University Medical Center, location de Boelelaan, The Netherlands.

Luca Boldrini (L)

Department of Bioimaging, Radiation Oncology and Hematology, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Anna Bruynzeel (A)

Department of Radiation Oncology, Amsterdam University Medical Center, location de Boelelaan, The Netherlands.

Juliane Hörner-Rieber (J)

Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany, Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Ina Jürgenliemk-Schulz (I)

Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands.

Frank Lagerwaard (F)

Department of Radiation Oncology, Amsterdam University Medical Center, location de Boelelaan, The Netherlands.

Helen McNair (H)

The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, United Kingdom.

Bas Raaymakers (B)

Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands.

Tine Schytte (T)

Department of Oncology, Odense University Hospital, Odense, Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Alison Tree (A)

The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, United Kingdom.

Vincenzo Valentini (V)

Department of Bioimaging, Radiation Oncology and Hematology, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Lotte Wilke (L)

Department of Radiation Oncology, University Hospital of Zurich, University of Zurich, Switzerland.

Daniel Zips (D)

Department of Radiation Oncology, University of Tübingen, Germany.

Claus Belka (C)

Department of Radiation Oncology, University Hospital, LMU Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH